The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Sang Ah | - |
dc.contributor.author | Park, Sue K. | - |
dc.contributor.author | Ahn, Sei-Hyun | - |
dc.contributor.author | Son, Byung Ho | - |
dc.contributor.author | Lee, Min Hyuk | - |
dc.contributor.author | Choi, Doo Ho | - |
dc.contributor.author | Noh, Dong-Young | - |
dc.contributor.author | Han, Wonshik | - |
dc.contributor.author | Lee, Eun Sook | - |
dc.contributor.author | Han, Seo Kyung | - |
dc.contributor.author | Kim, Lee Su | - |
dc.contributor.author | Jung, Yongsik | - |
dc.contributor.author | Kim, Ku Sang | - |
dc.contributor.author | Suh, Young Jin | - |
dc.contributor.author | Moon, Byung-In | - |
dc.contributor.author | Nam, Seok-Jin | - |
dc.contributor.author | Noh, Woo-Chul | - |
dc.contributor.author | Lee, Jeong Eon | - |
dc.contributor.author | Kim, Sung-Won | - |
dc.date.available | 2020-12-09T10:02:56Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.issn | 1738-6756 | - |
dc.identifier.issn | 2092-9900 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/35574 | - |
dc.description.abstract | Purpose: To estimate the cumulative risk till each age (penetrance) of breast and ovarian cancers among female family members with BRCA1 and BRCA2 mutation. Methods: Among the 61 BRCA1 mutation carriers in the 42 families and 47 BRCA2 mutation carriers in 31 families identified at 5 academic breast clinics, the probands were excluded to estimate the cumulative risk till each age of breast cancer in the Korean BRCA1 and BRCA2 carriers. Using Kaplan-Meier analyses, cumulative cancer risk estimates were determined. Results: By the age 70, the female breast cancer risk for the BRCA1 and BRCA2 mutation carriers was 72.1% (95% confidence interval [CI]=59.5% to 84.8%) and 66.3% (95% CI=41.2% to 91.5%), respectively, and the ovarian cancer risk was 24.6% (95% CI=0% to 50.3%) and 11.1% (95% CI=0% to 31.6%), respectively. The contralateral breast cancer risk at 5 years after primary breast cancer was estimated as 16.2% (95% CI=9.3% to 23.1%) for the 52 breast cancer patients with the BRCA1 mutation and 17.3% (95% CI=9.7% to 24.0%) for the 35 breast cancer patients with the BRCA2 mutation. Conclusion: The penetrance of BRCA mutations in Korea is largely consistent with the previous studies on Western populations. However, the small number of the cases, the high proportions of probands in the study subjects, the short term follow-up, and large confidence intervals are the limitations of the current study. The Korean Hereditary Breast Cancer Study (KOHBRA Study) may definitely answer this question. | - |
dc.format.extent | 8 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | KOREAN BREAST CANCER SOC | - |
dc.title | The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4048/jbc.2009.12.2.92 | - |
dc.identifier.scopusid | 2-s2.0-71049165469 | - |
dc.identifier.wosid | 000267771100006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF BREAST CANCER, v.12, no.2, pp 92 - 99 | - |
dc.citation.title | JOURNAL OF BREAST CANCER | - |
dc.citation.volume | 12 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 92 | - |
dc.citation.endPage | 99 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001361901 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | HEREDITARY BREAST | - |
dc.subject.keywordPlus | PROPHYLACTIC SURGERY | - |
dc.subject.keywordPlus | SERIES | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | PENETRANCE | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | FREQUENCY | - |
dc.subject.keywordAuthor | Breast neoplasms | - |
dc.subject.keywordAuthor | Ovarian neoplasms | - |
dc.subject.keywordAuthor | Penetrance of BRCA mutation | - |
dc.subject.keywordAuthor | Risk | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.